Canadian Association of Radiopharmaceutical Scientists

February 06, 2015
Government of Canada Announces Extension of National Research Universal (NRU) Reactor
The Honourable Greg Rickford, Canada's Minister of Natural Resources, today announced the Government of Canada's decision to support the extension of the operations of the National Research Universal (NRU) reactor from October 31, 2016, until March 31, 2018. The NRU is operated by Canadian Nuclear Laboratories Ltd. (CNL), a subsidiary of Atomic Energy of Canada Limited.
Today's announcement of the extension of the NRU is designed to help support global medical isotope demand between 2016 and 2018 in the unexpected circumstances of shortages, and Canadian Nuclear Laboratories will now begin decommissioning the NRU after March 31, 2018. read more

December 31, 2014
Guidance Document: A Guide for the Preparation of Applications for Authorization of Positron-emitting Radiopharmaceuticals for Use in Basic Clinical Research Studies

October 13, 2014
Mallinckrodt anounces a series of technetium-99m (Tc-99m) price increases over the next few years.

October 10, 2014
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals (C. Decristoforo, I. Penuelas, P. Elsinga, J. Ballinger, A. D. Winhorst, A. Verbruggen, F. Verzijlbergen, A. Chiti)

October 07, 2014
Safety, sanitary problems prompt scores of drug recalls
Two years after contaminated drugs from a compounding pharmacy killed 64 and sickened 750 with meningitis, the industry still struggles with serious safety problems and recalls affecting thousands of patients. Check out this story on

August 06, 2014
Minister Ambrose Announces Patient Involvement Pilot for Orphan Drugs
The Honourable Rona Ambrose, Minister of Health, announced today that the Government of Canada has launched a pilot project targeting patient input from Canadians with rare diseases to help inform future reviews of orphan drugs. For more information, please visit:

June 27, 2014
Latest issue of the AECL Nuclear Review now available

AECL is pleased to announce that the latest issue of the AECL Nuclear Review is now available. Featuring a broad range of articles and technical papers covering matters that are important to the scientific community, the 2014 June issue of Canada’s premier nuclear science and technology journal can be accessed directly at its brand new website (

From research innovation to spinoff success
UAlberta research team aims to revolutionize medical isotope manufacturing, helping patients and communities worldwide with launch of Belgravia Tech Inc. more

Funding boosts UAlberta research in race for new isotopes
UAlberta researchers receive $7M federal contribution for cyclotron project to provide critical medical isotopes. more

Harper Government Announces Recipients of Funding to Advance New Sources of Medical Isotopes
The Honourable Joe Oliver, Canada’s Minister of Natural Resources, speaking today at the Canadian Nuclear Association Conference and Trade Show, announced the signing of contribution agreements with three innovative Canadian organizations to develop new sources of supply of the key medical isotope, technetium-99m (Tc-99m). more

Cyclotron facility revolutionizes medical isotope manufacturing
Medical Isotope and Cyclotron Facility establishes UAlberta as a leader in addressing Canada’s isotope supply needs for medical diagnostics. more

Tc-99m Made on Multiple Cyclotrons
At a special session at the annual meeting of the American Association for the Advancement of Science, a team led by TRIUMF announced the successful production of the key medical isotope technetium-99m on cyclotrons already available in Ontario and British Columbia. more

Canadian Solution to Medical-Isotope Crisis Demonstrates that Cities Could Produce their own Medical Isotopes
With Canadian-developed tools and technology, a national team led by TRIUMF has reached a crucial milestone at the BC Cancer Agency in developing and deploying alternatives for supplying key medical isotopes. The team used a medical cyclotron that was designed and manufactured by Advanced Cyclotron Systems, Inc. (ACSI) of Richmond, BC, and successfully achieved large-scale production of technetium-99m (Tc-99m), sufficient for a metropolitan area. more

Medical isotope maker Nordion explores alternatives
Nordion is one of the world's leading producers of molybdenum-99, used in medical imaging, and it depends on raw material from AECL's aging facility in Chalk River, Ontario. more

Prairie Isotope Production Enterprise – PIPE Overview
PIPE is a not-for-profit corporation based in Manitoba. Our goal is to develop a reliable supply of the medical radioisotope technetium-99m (Tc-99m) for Canadian patients. more

Information on how a cyclotron makes technetium-99m
Many hospitals in major urban centres operate particle accelerators called cyclotrons. Cyclotrons work by accelerating hydrogen ions to a prerequisite energy and then direct them onto targets; in this case, the targets are made of enriched molybdenum-100 (Mo-100). more


Introducing the Canadian College of Radiopharmaceutical Scientists

As an initiative of the Canadian Association of Radiopharmaceutical Scientists a taskforce has been established to develop a plan for certification of radiopharmaceutical practitioners. Certification is initially to be voluntary, and upon successful adoption of the process by stakeholders, mandatory certification will be pursued.

Goals of certification include: setting and maintaining standards for the radiopharmaceutical sciences, providing a career structure for radiopharmaceutical scientists, promoting awareness of radiopharmaceutical science as a career choice, and facilitating movement nationally. read more

Last updated:February 19, 2015
| About Us | Radiopharmacy News | Members Only | | Meetings | Radiopharmacy Job Postings | Contact Us | Home |
Terms of Use
Copyright © 2014 Canadian Association of Radiopharceutical Scientists | Webmaster Mariusz Bereznicki